The Society for Immunotherapy of Cancer (SITC) is proud to host a guest symposia session at the American Association of Immunologists IMMUNOLOGY2026™ Annual Meeting. AAI is dedicated to advancing the field of immunology and fostering development opportunities for researchers at every career...
04-16-2026 | 12:45 - 14:15 ET Boston MA
The Society for Immunotherapy of Cancer (SITC) and the American Society for Transplantation and Cellular Therapy (ASTCT) are pleased to announce the publication of a comprehensive manuscript, “Advancing Cell Therapies for Solid Tumors: A Pathway to Overcome Biological, Operational, and...
In cooperation with the Food and Drug Administration (FDA), and as a service to our members, SITC will periodically distribute information about newly approved therapies for cancer patients. This helps the FDA inform oncologists and professionals in oncology-related fields of recent approvals in...
A Message from the President The Journal for ImmunoTherapy of Cancer ( JITC ) has long been integral to SITC’s mission to advance the science and application of cancer immunotherapy . As the field continues to evolve rapidly, JITC serves as a trusted global platform for advancing...
The Society for Immunotherapy of Cancer (SITC) is proud to collaborate with the Society of Interventional Oncology (SIO) for joint sessions, "When Combination Therapies Fail in HCC: Scientific Insights and Future Directions" and "Intratumoral Therapies in IO: Mechanisms, Delivery and Clinical...
05-28-2026 - 05-29-2026 Chicago IL
A Message from the President As we begin 2026, I’m pleased to share that SITC’s 2025 Year in Review is now live. It reflects a year defined by both complexity and innovation, and highlights the scientific progress, educational growth, and collective impact made possible by our global...
MANUSCRIPT TITLE: Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia v2.0 Draft Manuscript Summary The Society for Immunotherapy of Cancer (SITC) Acute Leukemia (AL) Immunotherapy Guideline...